« The Thing that Couldn't Die - $55M Drug Development Costs is Back | Main | KV Decision. Brings FDA Controversy? »

03/30/2011

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b014e6044ae43970c

Listed below are links to weblogs that reference CMS Rules for Provenge Reimbursement:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

Seeking Alpha waxes poetically (April 11th) on Provenge's $10B potential when 'off-label' uses covered by Medicaid
http://seekingalpha.com/article/262803-why-provenge-could-be-a-10-billion-drug-for-dendreon

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

July 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada